Sartorius | SRT3 - Cost Of Sales

Stock Price
237.90
Daily Change
-0.70 -0.29%
Monthly
-7.14%
Yearly
-2.06%
Q1 Forecast
230.71

Sartorius reported EUR450M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 8.13M 2.41M Mar/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.47M 1.19M Jun/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Sartorius EUR 450M 18.1M Sep/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025